YZ462 exhibits potent antibacterial activity against methicillin-resistant Staphylococcus aureus through bacterial membrane disruption
BMC Microbiology · 11.11.2025 · 25 (1)
DOI: 10.1186/s12866-025-04475-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Microbiology, online erschienen am 11.11.2025. Verfasst von Weikai Guo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Henan Province EngineeringTechnology Research Center of Rapid-Accuracy Medical Diagnostics, Department of Clinical Laboratory, the First Affiliated H…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, Cell Membrane. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Key Scientific Research Projects of Colleges and Universities in Henan Province, Natural Science Foundation of Henan, the Henan Province Key Research and Development and Promotion Project.
Abstract (Originalsprache)
BACKGROUND: The global rise of antibiotic resistance presents a critical public health challenge, with Staphylococcus aureus being a leading cause of hospital- and community-acquired infections. Methicillin-resistant S. aureus (MRSA) is particularly concerning due to its high prevalence, multidrug resistance, and association with severe morbidity and mortality. Developing novel small-molecule antimicrobial agents with reduced resistance susceptibility is essential to combat these infections. RESULTS: From our in-house compound library, we identified YZ462, a heteroaromatic-aryl scaffold compound, demonstrating potent antibacterial activity and low toxicity. YZ462 showed strong anti-MRSA effects through bacterial membrane disruption, increased permeability, and induction of endogenous ROS production. In vitro, it effectively killed both log-phase and stationary-phase MRSA while inhibiting biofilm formation and disrupting established biofilms. In vivo studies revealed significant reduction of bacterial loads and improved survival rates in infected animal models. Importantly, the major S. aureus membrane component cardiolipin (CL) directly interacted with YZ462 and attenuated its antibacterial activity, suggesting CL as a potential molecular target. CONCLUSIONS: Our study establishes YZ462 as a promising small-molecule candidate for MRSA treatment, featuring a unique mechanism of membrane disruption and ROS induction. These results confirm its potent antimicrobial activity and demonstrate therapeutic potential against MRSA infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan Province EngineeringTechnology Research Center of Rapid-Accuracy Medical Diagnostics, Department of Clinical Laboratory, the First Affiliated Hospital of Henan University, Henan University, Kaifeng, 475000, China.
- The Jointed National Laboratory of Antibody Drug Engineering, the First Affiliated Hospital of Henan University, Henan University, Kaifeng, 475000, China.
- Department of Microbiology, College of Basic Medical Sciences, Henan University, Kaifeng, 475000, China.
- Department of Clinical Laboratory, Henan Provincial People's Hospital, Zhengzhou, 450000, China.
- Henan Province EngineeringTechnology Research Center of Rapid-Accuracy Medical Diagnostics, Department of Clinical Laboratory, the First Affiliated Hospital of Henan University, Henan University, Kaifeng, 475000, China.…
- The Jointed National Laboratory of Antibody Drug Engineering, the First Affiliated Hospital of Henan University, Henan University, Kaifeng, 475000, China. liqiming82@126.com.
Förderung
- The Key Scientific Research Projects of Colleges and Universities in Henan Province
- Natural Science Foundation of Henan
- the Henan Province Key Research and Development and Promotion Project
- Provinces and ministries jointly building key projects of the Henan Provincial Health Commission
- Kaifeng Science and Technology Development Program Projects
Zitieren
APA
Guo, W., Zhao, Y., Yang, Y., Li, W., Wang, K., Zhou, F., Li, J., Li, X., Zhang, Y., Hu, B., Zhang, W., Wei, X., & Li, Q. (2025). YZ462 exhibits potent antibacterial activity against methicillin-resistant Staphylococcus aureus through bacterial membrane disruption. BMC Microbiology, 25(1). https://doi.org/10.1186/s12866-025-04475-6
Vancouver
Guo W, Zhao Y, Yang Y, Li W, Wang K, Zhou F, et al. YZ462 exhibits potent antibacterial activity against methicillin-resistant Staphylococcus aureus through bacterial membrane disruption. BMC Microbiology. 2025;25(1). doi:10.1186/s12866-025-04475-6
BibTeX
@article{Guo2025,
author = {Guo, Weikai and Zhao, Yanyang and Yang, Yuqing and Li, Wenyu and Wang, Kexiao and Zhou, Fang and Li, Jiaqi and Li, Xiangfeng and Zhang, Yuan and Hu, Biao and Zhang, Wenwen and Wei, Xin and Li, Qiming},
title = {YZ462 exhibits potent antibacterial activity against methicillin-resistant Staphylococcus aureus through bacterial membrane disruption},
journal = {BMC Microbiology},
year = {2025},
volume = {25},
number = {1},
doi = {10.1186/s12866-025-04475-6}
}
EUVIMED